Iovance Biotherapeutics, Inc. IOVA Total debt

Total debt at other companies

Bristol-Myers SquibbBMY

$43.33B-12.3%

Gilead SciencesGILD

$26.25B+5.2%

ImmunityBio, Inc.IBRX

$445.39M+32.2%

Cullinan Therapeutics, Inc.CGEM

$2.07M+36.3%

Artiva Biotherapeutics, Inc.ARTV

$9.85M-25.5%

IncyteINCY

$38.27M-9.8%

FAQ

What is Iovance Biotherapeutics, Inc.'s total debt?

Iovance Biotherapeutics, Inc. (IOVA) reported total debt of $46M in Q2 2026.

How has Iovance Biotherapeutics, Inc.'s total debt changed year-over-year?

Iovance Biotherapeutics, Inc.'s total debt decreased by 11.8% year-over-year, from $52.17M to $46M.

What is the long-term trend for Iovance Biotherapeutics, Inc.'s total debt?

Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s total debt has grown at a -1.3% compound annual growth rate (CAGR), from $51.66M to $48.44M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.